✦ LIBER ✦
Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate
✍ Scribed by Brown, J. P.; Roux, C.; Ho, P. R.; Bolognese, M. A.; Hall, J.; Bone, H. G.; Bonnick, S.; van den Bergh, J. P.; Ferreira, I.; Dakin, P.; Wagman, R. B.; Recknor, C.
- Book ID
- 125341357
- Publisher
- Springer-Verlag
- Year
- 2014
- Tongue
- English
- Weight
- 530 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0937-941X
No coin nor oath required. For personal study only.